Surveillance of the prevalence of autism and other serious developmental disabilities in children is needed to understand the magnitude of these health problems and to identify subgroups of the population at increased risk. Ongoing surveillance would also provide a mechanism for addressing public concerns about possible increases in the rate of autism in specific communities. At present, there are scant data on autism prevalence available for the United States. This article describes CDC's autism surveillance activities, including the challenges and limitations of these activities.